Grants and Contributions:
Title:
Comprehensive Reagent Platform for Genetic Medicine Development
Agreement Number:
937594
Agreement Value:
$995,000.00
Agreement Date:
Oct 17, 2019 - Mar 31, 2022
Description:
This project will support the firm in their development of a comprehensive lipid nanoparticle reagent technology and product line for the non-viral delivery of nucleic acids for both research and therapeutic applications. Combined with the firm’s suite of microfluidics-based instruments for lipid nanoparticle production, the new reagents developed in this project will enable a complete platform solution for the discovery, development and clinical manufacturing of genetic medicines.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6P 6T7
Reference Number:
172-2019-2020-Q3-937594
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
851285114
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 151 days.
Amendment Date
Jan 19, 2022
Recipient's Operating Name:
PNI
Recipient's Legal Name:
Precision Nanosystems ULC
Federal Riding Name:
Vancouver Granville
Federal Riding Number:
59036
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: